![](https://images.newscientist.com/wp-content/uploads/2024/04/01214544/SEI_198189278.jpg?width=1200)
Solution with the hepatocytes (liver cells) in suspension
LyGenesis
For the first time, a person has received an experimental treatment to transform one of their lymph nodes into a functioning miniature liver. We won’t know for months whether the therapy works, but if it does, it could revolutionise the treatment of liver disease.
“This is a technology that could, in just the next few years, potentially eliminate the wait list for liver transplants,” says Michael Hufford at LyGenesis, a biotechnology company in Pennsylvania.
…